Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

High-dose melphalan with autologous bone marrow transplantation for multiple myeloma.

Barlogie B, Hall R, Zander A, Dicke K, Alexanian R.

Blood. 1986 May;67(5):1298-301.

2.

High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma.

Barlogie B, Alexanian R, Dicke KA, Zagars G, Spitzer G, Jagannath S, Horwitz L.

Blood. 1987 Sep;70(3):869-72.

3.

Intermediate-dose melphalan (IDM) combined with G-CSF (filgrastim) is an effective and safe induction therapy for autologous stem cell transplantation in multiple myeloma.

Lokhorst HM, Sonneveld P, Wijermans PW, van Marwijk Kooy M, Meuwissen OJ, van Oers RH, van der Griend R, Dekker AW.

Br J Haematol. 1996 Jan;92(1):44-8.

PMID:
8562409
4.

Three courses of high dose therapy. Feasibility in the treatment of multiple myeloma--a "France autogreffe" study.

Colombat P, Milpied N, Laporte JP, Casassus P, Linassier C, Harousseu JL.

Cancer. 1994 Dec 1;74(11):2930-4.

5.

High-dose chemotherapy and autologous bone marrow transplantation for myeloma.

McElwain TJ, Selby PJ, Gore ME, Viner C, Meldrum M, Millar BC, Malpas JS.

Eur J Haematol Suppl. 1989;51:152-6. Review.

PMID:
2697587
6.

High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.

Kumar L, Raju GM, Ganessan K, Shawgi S, Menon H, Wadhwa J, Sharma A, Singh R, Kochupillai V.

Natl Med J India. 2003 Jan-Feb;16(1):16-21.

PMID:
12715951
8.

VAMP followed by high dose melphalan and autologous bone marrow transplantation for multiple myeloma.

McElwain TJ, Gore ME, Meldrum M, Viner C, Judson IR, Malpas JS.

Bone Marrow Transplant. 1989 Dec;4 Suppl 4:109-12.

PMID:
2697419
9.

Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients.

Tricot G, Jagannath S, Vesole D, Nelson J, Tindle S, Miller L, Cheson B, Crowley J, Barlogie B.

Blood. 1995 Jan 15;85(2):588-96. Review.

10.

Therapy of primary resistant and relapsed multiple myeloma.

Barlogie B, Alexanian R.

Onkologie. 1986 Aug;9(4):210-4.

PMID:
3531948
11.

High dose melphalan and autologous bone marrow transplantation in high risk myeloma.

Harousseau JL, Milpied N, Garand R, Bourhis JH.

Br J Haematol. 1987 Dec;67(4):493. No abstract available.

PMID:
3322363
12.

Phase-I-II study of high-dose melphalan and autologous marrow transplantation in adult patients with poor-risk non-Hodgkin's lymphomas.

Mascret B, Maraninchi D, Gastaut JA, Baume D, Sebahoun G, Lejeune C, Novakovitch G, Sainty D, Horchowski N, Tubiana N, et al.

Cancer Chemother Pharmacol. 1985;14(3):216-21.

PMID:
3888429
13.

Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma.

Giralt S, Aleman A, Anagnostopoulos A, Weber D, Khouri I, Anderlini P, Molldrem J, Ueno NT, Donato M, Korbling M, Gajewski J, Alexanian R, Champlin R.

Bone Marrow Transplant. 2002 Sep;30(6):367-73.

14.
15.
16.

Triple transplantation of autologous peripheral blood stem cells each time following conditioning with 100 mg/m2 of melphalan for multiple myeloma patients in poor performance status.

Rokicka M, Urbanowska E, Torosian T, Dwilewicz-Trojaczek J, Awedan A, Paluszewska M, Wiktor-Jedrzejczak W.

Transplant Proc. 2003 Sep;35(6):2352-4.

PMID:
14529939
17.

High-dose chemoradiotherapy and allogenic bone marrow transplantation in multiple myeloma.

Tura S, Cavo M, Gobbi M, Rosti G, Bandini G, Miggiano C, Albertazzi L, Grimaldi M, Visani G.

Eur J Haematol Suppl. 1989;51:191-5.

PMID:
2697591
18.

Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide.

Reece DE, Barnett MJ, Connors JM, Klingemann HG, O'Reilly SE, Shepherd JD, Sutherland HJ, Phillips GL.

Bone Marrow Transplant. 1993 Feb;11(2):139-46.

PMID:
8435663
19.

Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma.

Lokhorst HM, Sonneveld P, Cornelissen JJ, Joosten P, van Marwijk Kooy M, Meinema J, Nieuwenhuis HK, van Oers MH, Richel DJ, Segeren CN, Veth G, Verdonck LF, Wijermans PW.

Bone Marrow Transplant. 1999 Feb;23(4):317-22.

20.

High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplants.

Vesole DH, Barlogie B, Jagannath S, Cheson B, Tricot G, Alexanian R, Crowley J.

Blood. 1994 Aug 1;84(3):950-6.

Items per page

Supplemental Content

Support Center